Cargando…

Neoadjuvant Treatment for Gastric Cancer

Surgery is still considered to be the mainstay for the treatment of localized gastric cancer with negative margins (R0-resection) and an adequate lymph-node-dissection (D2-lymphadenectomy). Unfortunately, most cases of gastric cancer are only diagnosed at an advanced stage due to frequent recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuhmacher, Christoph, Reim, Daniel, Novotny, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Gastric Cancer Association 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705135/ https://www.ncbi.nlm.nih.gov/pubmed/23844320 http://dx.doi.org/10.5230/jgc.2013.13.2.73

Ejemplares similares

Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
por: Schirren, Rebekka, et al.
Publicado: (2020)

UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer
por: Dimpel, Rebekka, et al.
Publicado: (2022)

Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
por: Schirren, Rebekka, et al.
Publicado: (2021)

Parenteral nutrition during neoadjuvant chemotherapy for patients with non-metastatic gastric or esophago-gastric cancer to reduce postoperative morbidity (PERCOG): study protocol for a randomized controlled trial
por: Mueller, Tara C., et al.
Publicado: (2017)

Progress in neoadjuvant therapy for gastric cancer
por: Su, Peng-Fei, et al.
Publicado: (2022)

Perioperative transfusion of leukocyte depleted blood products in gastric cancer patients negatively influences oncologic outcome: A retrospective propensity score weighted analysis on 610 curatively resected gastric cancer patients
por: Reim, Daniel, et al.
Publicado: (2016)

Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
por: Ahmad, M. Usman, et al.
Publicado: (2022)

Novel Histologic Categorization Based on Lauren Histotypes Conveys Prognostic Information for Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
por: Schirren, Rebekka, et al.
Publicado: (2021)

Diverse ‘just-right’ levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer
por: Kohlruss, Meike, et al.
Publicado: (2021)

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
por: Yeh, Jen-Hao, et al.
Publicado: (2022)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

Current status and future perspectives on neoadjuvant therapy in gastric cancer
por: Ao, Sheng, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
por: Tong, Xie, et al.
Publicado: (2023)

Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer
por: Kohlruss, Meike, et al.
Publicado: (2021)

Different survival outcomes after curative R0-resection for Eastern Asian and European gastric cancer: Results from a propensity score matched analysis comparing a Korean and a German specialized center
por: Kim, Young-Woo, et al.
Publicado: (2016)

External Validation of an Eastern Asian Nomogram for Survival Prediction After Gastric Cancer Surgery in a European Patient Cohort
por: Reim, Daniel, et al.
Publicado: (2015)

Prognostic implications of the eighth edition of the union for international cancer control – classification for gastric cancer patients from specialized treatment centers in Germany and Korea: A STOBE-Compliant large-scale cohort study
por: Samm, Nicole, et al.
Publicado: (2020)

Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
por: Reddavid, Rossella, et al.
Publicado: (2018)

The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
por: Koerner, Anna S., et al.
Publicado: (2023)

Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives
por: Sato, Yasushi, et al.
Publicado: (2022)

Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations
por: Hiltner, Theresa, et al.
Publicado: (2023)

Perioperative versus total neoadjuvant chemotherapy in gastric cancer
por: Yang, Jessica, et al.
Publicado: (2023)

S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
por: Jung, Jong Yul, et al.
Publicado: (2008)

Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
por: Zhu, Zhi, et al.
Publicado: (2020)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

Expression Profiling of Stem Cell-Related Genes in Neoadjuvant-Treated Gastric Cancer: A NOTCH2, GSK3B and β-catenin Gene Signature Predicts Survival
por: Bauer, Lukas, et al.
Publicado: (2012)

Neoadjuvant nab-paclitaxel in the treatment of breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2016)

Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer
por: Lambert, Aurélien, et al.
Publicado: (2021)

Post-Neoadjuvant Treatment Strategies in Breast Cancer
por: Matuschek, Christiane, et al.
Publicado: (2022)

Gastrectomy for cancer beyond life expectancy. A comprehensive analysis of oncological gastric surgery in Germany between 2008 and 2018
por: Berlet, Maximilian, et al.
Publicado: (2022)

Neoadjuvant Gastric Cancer Treatment and Associated Nutritional Critical Domains for the Optimization of Care Pathways: A Systematic Review
por: Correia, Marta, et al.
Publicado: (2023)

Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer
por: Hoffmann, Anne, et al.
Publicado: (2021)

Neoadjuvant Treatment in Rectal Cancer: Actual Status
por: Garajová, Ingrid, et al.
Publicado: (2011)

Surgery for Pancreatic Cancer after neoadjuvant treatment
por: Hackert, Thilo
Publicado: (2018)

Recent Advances in the Neoadjuvant Treatment of Breast Cancer
por: Rubovszky, Gábor, et al.
Publicado: (2017)

PRE-OPERATIVE GASTRIC GIST DOWNSIZING: THE IMPORTANCE OF NEOADJUVANT THERAPY
por: RODRIGUES, João Bernardo Sancio Rocha, et al.
Publicado: (2019)

Extended Lymphadenectomy for Gastric Cancer in the Neoadjuvant Era: Current Status, Clinical Implications and Contentious Issues
por: Marano, Luigi, et al.
Publicado: (2023)

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
por: Hu, Shen-Bao, et al.
Publicado: (2019)

My burning issues in the neoadjuvant treatment for breast cancer
por: Bergen, Elisabeth S., et al.
Publicado: (2017)

ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer
por: Vrana, David, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vge1pmmtnd6i18ljm1mhv26rad